内脏脂肪代谢指标与脂肪性肝病肝纤维化的相关性:基于NHANES横断面调查OA
Correlations between visceral fat metabolism indices and liver fibrosis in steatotic liver disease:a cross-sectional study based on NHANES
目的 探讨内脏脂肪代谢指标[代谢性内脏脂肪评分(METS-VF)、胰岛素抵抗代谢评分(METS-IR)、脂质蓄积指数(LAP)、内脏脂肪指数(VAI)和心脏代谢指数(CMI)]与脂肪性肝病(SLD)人群肝纤维化的关系.方法 基于美国国家健康与营养检查调查(NHANES)2017-2020年数据,采用加权多因素Logistic回归、趋势性分析探讨内脏脂肪代谢指标与SLD肝纤维化的关系;构建限制性立方样条模型探讨两者是否存在非线性关系;绘制受试者工作特征(ROC)曲线简单评估内脏脂肪代谢指标对肝纤维化的诊断效能.结果 在SLD全人群及代谢功能障碍相关脂肪性肝病(MASLD)亚群(92.6%)中,Logistic回归分析显示,METS-VF、METS-IR和LAP与肝纤维化风险呈显著正相关,且风险随指标四分位数升高而递增(均P趋势<0.01).在完全校正模型中,其最高四分位数的肝纤维化风险显著升高(全人群OR分别为25.622、11.426、5.651;MASLD亚群OR分别为29.538、18.346、5.526;均P<0.01).限制性立方样条分析提示,METS-VF在全人群及MASLD亚群中与肝纤维化均呈线性关联(Poverall<0.05,Pnon-linear>0.05);METS-IR在MASLD亚群中与肝纤维化呈非线性关联(Poverall<0.05,Pnon-linear<0.05);METS-IR 在 SLD 全人群中与肝纤维化呈线性关联(Poverall<0.05,Pnon-linear=0.251);LAP 与 CMI 在SLD全人群和MASLD亚群中与肝纤维化均呈非线性关联(Poverall<0.05,Pnon-linear<0.05).ROC曲线分析进一步证实,无论在SLD全人群或MASLD亚群中,METS-VF与METS-IR预测肝纤维化的效能(曲线下面积值)均显著优于传统指标(P<0.001).结论 SLD肝纤维化风险随METS-VF的增加显著升高,其有望作为SLD肝纤维化的无创筛查工具.
Objective To investigate the associations of visceral fat metabolism indices[the Metabolic Score for Visceral Fat(METS-VF),the Metabolic Score for Insulin Resistance(METS-IR),the lipid accumulation product(LAP),the visceral adiposity index(VAI),and the cardiometabolic index(CMI)]with liver fibrosis in individuals with steatotic liver disease(SLD).Methods Based on data of year 2017 to 2020 from the National Health and Nutrition Examination Survey(NHANES),weigh-ted multivariate Logistic regression and trend analysis were used to explore the relationships between visceralfat metabolism indices and liver fibrosis in SLD.Restricted cubic spline models were constructed to examine potential nonlinear relationships.Receiver operating characteristic(ROC)curves were plotted to briefly evaluate the diagnostic performance of visceral fat metabolism indices for liver fibro-sis.Results In the entire SLD population and the metabolic dysfunction-associated steatotic liver disease(MASLD)subgroup(92.6%),the Logistic regression analysis revealed that METS-VF,METS-IR,and LAP were significantly positively associated with the risk of liver fibrosis,with risks increasing progressively across quartiles of these indices(Ptrend<0.01).In fully adjusted models,the highest quartiles of these indices were associated with a significantly elevated risk of liver fibrosis(OR for the entire population:25.622,11.426 and 5.651,respectively;OR for the MASLD sub-group:29.538,18.346 and 5.526,respectively;all P<0.01).Restricted cubic spline analysis indicated that METS-VF exhibited a linear association with liver fibrosis in both the entire population and the MASLD subgroup(Poverall<0.05,Pnon-linear>0.05);METS-IR showed a nonlinear associa-tion with liver fibrosis in the MASLD subgroup(Poverall<0.05,Pnon-linear<0.05);METS-IR demon-strated a linear association with liver fibrosis in the entire SLD population(Poverall<0.05,Pnon-linear=0.251);LAP and CMI exhibited nonlinear associations with liver fibrosis in both the entire SLD population and the MASLD subgroup(Poverall<0.05,Pnon-linear<0.05).ROC curve analysis further confirmed that in both the entire SLD population and the MASLD subgroup,the predictive perform-ance(area under the curve values)of METS-VF and METS-IR for liver fibrosis were significantly superior to those of traditional indices(P<0.001).Conclusion The risk of liver fibrosis in SLD increases significantly with rising METS-VF,suggesting its potential as a non-invasive screening tool for liver fibrosis in SLD.
尚琪;贺改霞;梁肖;杜紫薇;张帅
西安交通大学第二附属医院肝病科,陕西西安,710004||西安交通大学第二附属医院生物诊断治疗国家地方联合工程研究中心,陕西西安,710004西安交通大学第二附属医院肝病科,陕西西安,710004||西安交通大学第二附属医院生物诊断治疗国家地方联合工程研究中心,陕西西安,710004西安交通大学第二附属医院生物诊断治疗国家地方联合工程研究中心,陕西西安,710004西安交通大学第二附属医院生物诊断治疗国家地方联合工程研究中心,陕西西安,710004西安大兴医院皮肤与整形美容科,陕西西安,710082
医药卫生
美国国家健康与营养检查调查肝纤维化肝硬化代谢功能障碍相关脂肪性肝病代谢性内脏脂肪评分胰岛素抵抗代谢评分脂质蓄积指数内脏脂肪指数心脏代谢指数
《实用临床医药杂志》 2026 (3)
16-23,8
国家自然科学基金青年科学基金项目(81802455)陕西省自然科学基金项目(2019JQ-962)
评论